Aims:Cervical screening, currently performed by cervical cytology, depends for its success on the timely detection of malignant lesions. The presence of high-risk human papillomavirus (hrHPV) is associated with an increased risk of subsequent high-grade cervical intra-epithelial neoplasia (CIN2/3) and cervical cancer. In this study we determined to which extent hrHPV is present in cervical smears with a high a priori chance of being false negative, ie, in normal smears preceding CIN2/3.
Methods: Archival specimens of 187 women with CIN2/3 and preceding normal conventional smears were identified retrospectively. Of these specimens, 144 (77%) had adequate cytologic samples for further HPV DNA testing.
Results: Of 144 CIN2/3 lesions, preceding normal smears showed hrHPV positivity in 80% of cases. Of the hrHPV positive smears 69% were upgraded cytologically at rescreening compared to 24% of hrHPV negative smears (p<0.001). Upgrading of smears was not associated with specific hrHPV types (p=0.217). In over 90% of cases, type-concordance in both smear and CIN2/3 lesion was demonstrated.
Conclusions: HrHPV is present in a high proportion of normal archival smears preceding CIN2/3 and false negative cytology was highly associated with the presence of hrHPV. This supports the current notion that hrHPV testing can be used as a primary cervical screening tool. If so, hrHPV positive cervical smears should be carefully examined for cytological abnormalities to reduce false negative cervical cytology.
- Cervical Intra-epithelial Neoplasia
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.